Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00137410 | Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee | PHASE3 | COMPLETED | 200 | — | — | Nov 1, 2002 | Mar 1, 2006 | Jun 10, 2008 | 16 | Italy |
| Name | Type | Description |
|---|---|---|
| Celebrex | DRUG | - |
Inclusion Criteria: * diagnosis of OA of the knee according to the ACR Classification Criteria for osteoarthritis; * patients in flare Exclusion Criteria: * any concomitant inflammatory rheumatic condition which may interfere with the assessment of OA * clinical or radiological evidence of chondr...